"The conference included a broad range of important studies that could inform use of currently approved drugs, and first results of a new integrase inhibitor.
"First results of new integrase compound: GSK1349572
...
"Raltegravir in treatment-naive patients
...
"Nevirapine vs atazanavir/ritonavir in treatment-naive patients: ARTEN study
...
"Darunavir/r monotherapy studies
...
Maraviroc results similar to efavirenz when analysed using more sensitive tropism test"
Read more in i-base, September/October 2009.
0 comments:
Post a Comment